Biogen to Invest $200M to Expand RTP Facility to Produce Gene Therapies Date Published: March 4, 2021 By NC Biotech North Carolina’s gene and cell therapy magnet has attracted an investment from one of the state’s original…
Latest spinoff from UNC’s Gene Therapy Center wants to find a cure for hemophilia Date Published: January 13, 2021 UNC-Chapel Hill’s gene therapy center has birthed yet another startup in the Triangle. The latest spinoff is Raleigh-based GeneVentiv Therapeutics,…
Durham biotech uses new funding to acquire gene therapy for eye disease Date Published: July 29, 2020 A Hatteras-backed, early-stage life science company has used its new funding to acquire the exclusive rights to gene therapy platform…
AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System Date Published: June 23, 2020 Research Triangle Park, N.C. – June 23, 2020 – Asklepios BioPharmaceutical, Inc. (AskBio), a leading, clinical-stage adeno-associated virus (AAV) gene…
In Praise of Lesser-Sung Life Sciences Clusters Date Published: June 8, 2020 The Research Triangle Region is an emerging gene therapy hub, and being one of the strongest life science hubs in…
RTP gene tech firm lands deal worth up to $90M for 8 nervous system therapies Date Published: November 14, 2019 By Rick Smith, WRAL TechWire RESEARCH TRIANGLE PARK – StrideBio, a life science startup focused on gene editing technology, has…